enoxaparin
ApprovedCompleted 1 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Venous Thrombosis
Conditions
Venous Thrombosis
Trial Timeline
Dec 1, 2004 → Jan 1, 2009
NCT ID
NCT00265993About enoxaparin
enoxaparin is a approved stage product being developed by Sanofi for Venous Thrombosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00265993. Target conditions include Venous Thrombosis.
What happened to similar drugs?
5 of 20 similar drugs in Venous Thrombosis were approved
Approved (5) Terminated (3) Active (13)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (11)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04492254 | Phase 3 | Terminated |
| NCT00908960 | Phase 2 | Completed |
| NCT00518245 | Approved | Terminated |
| NCT00622115 | Phase 1 | Completed |
| NCT00723216 | Phase 3 | Completed |
| NCT00444652 | Approved | UNKNOWN |
| NCT00769873 | Phase 2 | Terminated |
| NCT00413374 | Pre-clinical | Completed |
| NCT00265993 | Approved | Completed |
| NCT00043784 | Phase 3 | Completed |
| NCT00289042 | Approved | Completed |
Competing Products
20 competing products in Venous Thrombosis